Efficacy, Safety and Tolerability of Cadazolid in Subjects With Clostridium Difficile Associated Diarrhea (CDAD)
Completed · Phase 2 · Has a placebo group
Conditions studied: Clostridium Difficile Infection
In brief
Cadazolid is a new antibiotic developed for the treatment of Clostridiun difficile associated diarrhea (CDAD), also known as Clostridium Difficile Infection (CDI). The purpose of the study was to evaluate the efficacy and safety of different doses of cadazolid in order to find the dose of cadazolid to be used for further clinical development of the compound in subjects with CDAD.
Key facts
- Study ID
- NCT01222702
- Run by
- Actelion
- People needed
- 84
- Starts
- 2011-01-25
- Expected to finish
- 2012-11-12
- Last updated by the study team
- 2017-06-14
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Clinical Investigative Site 6902 — Newark, Delaware, United States
- Clinical Investigative Site 6919 — Jacksonville, Florida, United States
- Clinical Investigative Site 6938 — Orlando, Florida, United States
- Clinical Investigative Site 6930 — Decatur, Georgia, United States
- Clinical Investigative Site 6935 — Marietta, Georgia, United States
- Clinical Investigative Site 6915 — Idaho Falls, Idaho, United States
- Clinical Investigative Site 6906 — Chicago, Illinois, United States
- Clinical Investigative Site 6917 — Boston, Massachusetts, United States
- Clinical Investigative Site 6936 — Royal Oak, Michigan, United States
- Clinical Investigative Site 6903 — Columbus, Ohio, United States
- Clinical Investigative Site 6914 — Houston, Texas, United States
- Clinical Investigative Site 6605 — Victoria, British Columbia, Canada
- Clinical Investigative Site 6601 — Montreal, Quebec, Canada
- Clinical Investigative Site 6606 — Sherbrooke, Quebec, Canada
- Clinical Ivestigative Site 6602 — Calgary, Canada
- Clinical Investigative Site 6632 — Cologne, Germany
- Clinical Investigative Site 6633 — Regensburg, Germany
- Clinical Investigative Site 6634 — Ulm, Germany
- Clinical Investigative Site 6734 — Busto Arsizio, Italy
- Clinical Investigative Site 6735 — Modena, Italy
- Clinical Investigative Site 6702 — Örebro, Sweden
- Clinical Investigative Site 6801 — Blackpool, United Kingdom
- Clinical Investigative Site 6804 — York, United Kingdom
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.